Antifungal potential of punicalagin against Cryptococcus neoformans species complex

• Autor(a) principal: Silva, Thaísa Cristina
• Data de Publicação: 2018
• Outros Autores: Zara, Ana Laura de Sene Amâncio, Sá, Fabyola Amaral da Silva, Bara, Maria Teresa Freitas, Ávila, Renato Ivan de, Costa, Carolina Rodrigues, Valadares, Marize Campos, Santos, Andressa Santana dos, Freitas, Vivianny Aparecida Queiroz, Silva, Maria do Rosário Rodrigues
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
• Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/151786
• topic: Punicalagin; Lafoensia pacari A.St.-Hil; Cytotoxicity; Antifungal activity; Cryptococcus neoformans species Complex

This study evaluated the antifungal activity and cytotoxicity profile of the ellagitannin punicalagin, a compound extracted from the L. pacari A.St.-Hil (Lythraceae) leaf, against Cryptococcus neoformans species complex. Minimum inhibitory concentrations (MIC) were checked using the broth microdilution method. Minimum fungicidal concentrations (MFC) and time of death were used to confirm the antifungal activity of the compound. The in vitro cytotoxicity of punicalagin was tested in BALB/c3T3 fibroblasts and A549 human lung cancer cell line, while the hemolytic potential was tested on sheep erythrocytes. The morphological changes induced in yeast strains by the presence of punicalagin were also analyzed. Tested on eight isolates of the C. neoformans complex punicalagin showed MIC of 0.5 to 4.0 μg/mL and MFC> 256 μg/mL. Punicalagin also demonstrated a good growth inhibitory activity in time-kill curves, but it was not able to achieve a statistically significant reduction of fungal growth suggesting a fungistatic effect of the compound. In vitro cytotoxicity studies using the two cell lines showed that punicalagin has low activity on these cells and no activity on sheep erythrocytes. Morphological changes were seen in the yeasts strains studied when treated with punicalagin. Therefore, punicalagin is a potential antifungal for important pathogenic yeasts and presents a low cytotoxicity profile associated with no hemolytic effects.